http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004064753-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7892610dad5eb03b08f032089a1eec1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_096e2a5001e0e74ad01e00d951e508ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02d2b7b5831d88d46035d44c54256fb0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
filingDate 2004-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73a9107110ddf399cd6ed55eef7bc5c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb51cfedc08a19340b6b7ef9284e4f4f
publicationDate 2004-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004064753-A3
titleOfInvention Use of n-desmethylclozapine to treat human neuropsychiatric disease
abstract Disclosed herein is a method to treat neuropsychiatric diseases including psychosis, affective disorders, dementia, neuropathic pain, and glaucoma. Treatment is carried out by administering a therapeutically effective amount of N-desmethylclozapine to a patient suffering from a neuropsychiatric disease.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9566271-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8921393-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9050343-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9211289-B2
priorityDate 2003-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02060870-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135409468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409724988

Total number of triples: 36.